Jaren Landen - Nov 18, 2024 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Clinical Dev. Officer
Signature
/s/ Eric J. Schoen by Power of Attorney
Stock symbol
SAVA
Transactions as of
Nov 18, 2024
Transactions value $
$0
Form type
4
Date filed
11/20/2024, 04:39 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAVA Stock Option (Right to Buy) Award $0 +85K $0.00 85K Nov 18, 2024 Common Stock 85K $27.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on November 18, 2025.